From professional translators, enterprises, web pages and freely available translation repositories.
idursulfase
idursulfáza
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
elaprase idursulfase
elaprase idursulfáza
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each ml contains 2 mg of idursulfase
každý ml obsahuje 2 mg idursulfázy.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
each vial contains 6 mg of idursulfase.
každá injekčná liekovka obsahuje 6 mg idursulfázy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial of elaprase contains 6 mg of idursulfase.
každá injekčná liekovka elaprase obsahuje 6 mg idursulfázy.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
idursulfase has a molecular weight of approximately 76 kd.
idursulfáza má molekulárnu hmotnosť približne 76 kda.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
marginally weighted (om) mean (se) idursulfase placebo
(pozorovaný rozdiel) (smerodajná chyba)
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
elaprase 2 mg/ml concentrate for solution for infusion idursulfase
elaprase 2 mg/ml infúzny koncentrát idursulfáza
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
animal studies have shown excretion of idursulfase in breast milk.
Štúdie na zvieratách dokázali vylučovanie idursulfázy do materského mlieka.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial contains 6 mg of idursulfase each ml contains 2 mg of idursulfase
každý ml obsahuje 2 mg idursulfázy.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
idursulfase is produced in a human cell line by genetic engineering technology.
idursulfáza sa vyrába v ľudskej bunkovej línii technológiou génového inžinierstva.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
idursulfase is produced by recombinant dna technology in a continuous human cell line.
idursulfáza sa vyrába rekombinantnou technológiou dna v kontinuálnej ľudskej bunkovej línii.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
idursulfase has no or negligible influence on the ability to drive and use machines.
idursulfáza nemá žiadny alebo má zanedbateľný vplyv na schopnosť viesť vozidlá a obsluhovať stroje.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
elaprase is a concentrate for solution for infusion that contains the active substance idursulfase.
elaprase je koncentrát na infúzny roztok, ktorý obsahuje účinnú látku idursulfázu.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
as a precautionary measure, it is preferable to avoid the use of idursulfase during pregnancy.
ako preventívne opatrenie je vhodnejšie vyhnúť sa užívaniu idursulfázy počas gravidity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each vial of elaprase is intended for single use only and contains 6 mg of idursulfase in 3 ml of solution.
každá injekčná liekovka elaprase je určená iba na jedno použitie a obsahuje 6 mg idursulfázy v 3 ml roztoku.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
treatment of hunter syndrome patients with intravenous idursulfase provides exogenous enzyme for uptake into cellular lysosomes.
liečba pacientov trpiacich hunterovým syndrómom intravenózne podávanou idursulfázou zabezpečuje exogénny enzým, prijímaný do celulárnych lyzozómov.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
based on its metabolism in cellular lysosomes, idursulfase would not be a candidate for cytochrome p450 mediated interactions.
idursulfáza by s ohľadom na jej metabolizmus v celulárnych lyzozómoch nemala byť kandidátom na interakcie sprostredkovávané cytochrómom p450.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
the reduction of urinary gag excretion was somewhat less in patients for whom circulating anti-idursulfase antibodies were detected.
u pacientov, u ktorých boli detegované protilátky na idursulfázu v obehu, bol pokles vylučovania gag v moči o niečo nižší.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
patients treated with idursulfase may develop infusion-related reactions (see section 4.8).
u pacientov liečených idursulfázou sa môžu prejaviť reakcie súvisiace s infúziou (pozri časť 4.8).
Last Update: 2017-04-26
Usage Frequency: 3
Quality: